These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 7742222

  • 1. Increased glomerular and urinary malondialdehyde in puromycin aminonucleoside-induced proteinuria in rats.
    Srivastava RN, Diven S, Kalia A, Travis LB, Ansari NH.
    Pediatr Nephrol; 1995 Feb; 9(1):48-51. PubMed ID: 7742222
    [Abstract] [Full Text] [Related]

  • 2. Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria.
    Thakur V, Walker PD, Shah SV.
    Kidney Int; 1988 Oct; 34(4):494-9. PubMed ID: 2848972
    [Abstract] [Full Text] [Related]

  • 3. Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries.
    Kawamura T, Yoshioka T, Bills T, Fogo A, Ichikawa I.
    Kidney Int; 1991 Aug; 40(2):291-301. PubMed ID: 1942778
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Amelioration of antioxidant enzyme suppression and proteinuria in cyclosporin-treated puromycin nephrosis.
    Wang JS, Yang AH, Chen SM, Young TK, Chiang H, Liu HC.
    Nephron; 1993 Aug; 65(3):418-25. PubMed ID: 8289993
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Involvement of thromboxane A2, leukotrienes and free radicals in puromycin nephrosis in rats.
    Shibouta Y, Terashita Z, Imura Y, Shino A, Kawamura M, Ohtsuki K, Ohkawa S, Nishikawa K, Fujiwara Y.
    Kidney Int; 1991 May; 39(5):920-9. PubMed ID: 2067208
    [Abstract] [Full Text] [Related]

  • 8. Differential nephron HO-1 expression following glomerular epithelial cell injury.
    Datta PK, Reddy S, Sharma M, Lianos EA.
    Nephron Exp Nephrol; 2006 May; 103(4):e131-8. PubMed ID: 16601358
    [Abstract] [Full Text] [Related]

  • 9. The effect of recombinant human insulin-like growth factor-I on chronic puromycin aminonucleoside nephropathy in rats.
    Trachtman H, Maesaka J, Futterweit S, Ma C, Valderrama E, Chan JC, Chan W.
    Pediatr Res; 1996 Jan; 39(1):13-19. PubMed ID: 8825380
    [Abstract] [Full Text] [Related]

  • 10. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
    Kim BS, Park HC, Kang SW, Choi KH, Ha SK, Han DS, Lee HY.
    Yonsei Med J; 2005 Feb 28; 46(1):141-8. PubMed ID: 15744817
    [Abstract] [Full Text] [Related]

  • 11. Time course of lipid peroxidation in puromycin aminonucleoside-induced nephropathy.
    Fawcett JP, Jiang R, Walker RJ.
    Res Commun Mol Pathol Pharmacol; 1994 Nov 28; 86(2):227-34. PubMed ID: 7881871
    [Abstract] [Full Text] [Related]

  • 12. Severe proteinuria without impairment of sodium and volume excretion after puromycin aminonucleoside administration in rats.
    Palluk R, Veress AT, Sonnenberg H.
    Pharmacology; 1989 Nov 28; 38(4):214-25. PubMed ID: 2526952
    [Abstract] [Full Text] [Related]

  • 13. Protection of alpha(3) integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat.
    Kojima K, Matsui K, Nagase M.
    Am J Kidney Dis; 2000 Jun 28; 35(6):1175-85. PubMed ID: 10845833
    [Abstract] [Full Text] [Related]

  • 14. Effect of a novel free radical scavenger, edaravone, on puromycin aminonucleoside induced nephrosis in rats.
    Someya T, Kaneko K, Yamada T, Yamashiro Y.
    Pediatr Nephrol; 2005 Oct 28; 20(10):1430-4. PubMed ID: 16079985
    [Abstract] [Full Text] [Related]

  • 15. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y, Shirato I, Maeda A, Kobayashi N, Liao J, Shou I, Fukui M, Tomino Y.
    J Nephrol; 2002 Oct 28; 15(1):36-41. PubMed ID: 11936424
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of puromycin-induced renal injury by a superoxide dismutase derivative with prolonged in vivo half-life.
    Nishimura Y, Nakayama M, Sato T, Tomita K, Inoue M.
    Nephron; 1995 Oct 28; 70(4):460-5. PubMed ID: 7477653
    [Abstract] [Full Text] [Related]

  • 17. Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier.
    McCarthy ET, Sharma R, Sharma M.
    Kidney Int; 2005 Jan 28; 67(1):152-6. PubMed ID: 15610238
    [Abstract] [Full Text] [Related]

  • 18. Puromycin aminonucleoside induces glomerular epithelial cell apoptosis.
    Sanwal V, Pandya M, Bhaskaran M, Franki N, Reddy K, Ding G, Kapasi A, Valderrama E, Singhal PC.
    Exp Mol Pathol; 2001 Feb 28; 70(1):54-64. PubMed ID: 11170791
    [Abstract] [Full Text] [Related]

  • 19. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
    Ebihara I, Nakamura T, Tomino Y, Koide H.
    Nephrol Dial Transplant; 1997 May 28; 12(5):1001-6. PubMed ID: 9175058
    [Abstract] [Full Text] [Related]

  • 20. Glomerular expression of smooth-muscle myosin heavy-chain isoforms in aminonucleoside nephrosis in rats.
    Nakamura T, Kimura K, Ebihara I, Takahashi T, Tomino Y, Aikawa M, Yazaki Y, Nagai R, Koide H.
    Clin Sci (Lond); 1995 Jul 28; 89(1):45-52. PubMed ID: 7671567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.